Cargando…

A case report of glucose transporter 1 deficiency syndrome with growth hormone deficiency diagnosed before starting ketogenic diet

BACKGROUND: Growth failure and growth hormone deficiency (GHD) have been reported as one accessory feature of GLUT1 deficiency syndrome (GLUT1DS), considered so far as a long-term adverse effects of ketogenic diet which is used to treat this condition. CASE PRESENTATION: We report the case of a 10-y...

Descripción completa

Detalles Bibliográficos
Autores principales: Tornese, Gianluca, Patti, Giuseppa, Pellegrin, Maria Chiara, Costa, Paola, Faletra, Flavio, Faleschini, Elena, Barbi, Egidio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448353/
https://www.ncbi.nlm.nih.gov/pubmed/32847563
http://dx.doi.org/10.1186/s13052-020-00888-3
_version_ 1783574482933252096
author Tornese, Gianluca
Patti, Giuseppa
Pellegrin, Maria Chiara
Costa, Paola
Faletra, Flavio
Faleschini, Elena
Barbi, Egidio
author_facet Tornese, Gianluca
Patti, Giuseppa
Pellegrin, Maria Chiara
Costa, Paola
Faletra, Flavio
Faleschini, Elena
Barbi, Egidio
author_sort Tornese, Gianluca
collection PubMed
description BACKGROUND: Growth failure and growth hormone deficiency (GHD) have been reported as one accessory feature of GLUT1 deficiency syndrome (GLUT1DS), considered so far as a long-term adverse effects of ketogenic diet which is used to treat this condition. CASE PRESENTATION: We report the case of a 10-year-old Caucasian boy referred for short stature (height − 2.56 SDS) and delayed growth (growth velocity − 4.33 SDS) who was diagnosed with GHD and started treatment with recombinant human growth hormone (rhGH). Because of his history of seizures with infantile onset, deceleration of head growth with microcephaly, ataxia, and moderate intellectual disability, a lumbar puncture was performed, which revealed a low CSF glucose concentration with a very low CSF-to-blood glucose ratio (< 0.4), and genetic tests detected a SLC2A1 gene exon 1 deletion confirming a diagnosis of GLUT1DS. Ketogenic diet was started. After 5.5 years of rhGH treatment his height was normalized (− 1.15 SDS). No side effects were reported during treatment, particularly on glycemic metabolism. CONCLUSIONS: This is the first case of GHD in a Caucasian boy with GLUT1DS diagnosed before starting ketogenic diet, with a good response to rhGH treatment and absence of side effects. We speculate that GHD may represent a poorly recognized clinical feature of GLUT1DS rather than a complication due to ketogenic diet. Under-diagnosis may derive from the fact that growth failure is usually ascribed to ketogenic diet and therefore not further investigated. Pediatric neurologists need to be alerted to the possible presence of GHD in patients with GLUT1DS with slow growth, while pediatric endocrinologist need to refer GHD patients with additional features (motor and cognitive developmental delay, seizures with infantile onset, deceleration of head growth with acquired microcephaly, movement disorder with ataxia, dystonia, and spasticity) that may suggest GLUT1DS.
format Online
Article
Text
id pubmed-7448353
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74483532020-08-27 A case report of glucose transporter 1 deficiency syndrome with growth hormone deficiency diagnosed before starting ketogenic diet Tornese, Gianluca Patti, Giuseppa Pellegrin, Maria Chiara Costa, Paola Faletra, Flavio Faleschini, Elena Barbi, Egidio Ital J Pediatr Case Report BACKGROUND: Growth failure and growth hormone deficiency (GHD) have been reported as one accessory feature of GLUT1 deficiency syndrome (GLUT1DS), considered so far as a long-term adverse effects of ketogenic diet which is used to treat this condition. CASE PRESENTATION: We report the case of a 10-year-old Caucasian boy referred for short stature (height − 2.56 SDS) and delayed growth (growth velocity − 4.33 SDS) who was diagnosed with GHD and started treatment with recombinant human growth hormone (rhGH). Because of his history of seizures with infantile onset, deceleration of head growth with microcephaly, ataxia, and moderate intellectual disability, a lumbar puncture was performed, which revealed a low CSF glucose concentration with a very low CSF-to-blood glucose ratio (< 0.4), and genetic tests detected a SLC2A1 gene exon 1 deletion confirming a diagnosis of GLUT1DS. Ketogenic diet was started. After 5.5 years of rhGH treatment his height was normalized (− 1.15 SDS). No side effects were reported during treatment, particularly on glycemic metabolism. CONCLUSIONS: This is the first case of GHD in a Caucasian boy with GLUT1DS diagnosed before starting ketogenic diet, with a good response to rhGH treatment and absence of side effects. We speculate that GHD may represent a poorly recognized clinical feature of GLUT1DS rather than a complication due to ketogenic diet. Under-diagnosis may derive from the fact that growth failure is usually ascribed to ketogenic diet and therefore not further investigated. Pediatric neurologists need to be alerted to the possible presence of GHD in patients with GLUT1DS with slow growth, while pediatric endocrinologist need to refer GHD patients with additional features (motor and cognitive developmental delay, seizures with infantile onset, deceleration of head growth with acquired microcephaly, movement disorder with ataxia, dystonia, and spasticity) that may suggest GLUT1DS. BioMed Central 2020-08-26 /pmc/articles/PMC7448353/ /pubmed/32847563 http://dx.doi.org/10.1186/s13052-020-00888-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Tornese, Gianluca
Patti, Giuseppa
Pellegrin, Maria Chiara
Costa, Paola
Faletra, Flavio
Faleschini, Elena
Barbi, Egidio
A case report of glucose transporter 1 deficiency syndrome with growth hormone deficiency diagnosed before starting ketogenic diet
title A case report of glucose transporter 1 deficiency syndrome with growth hormone deficiency diagnosed before starting ketogenic diet
title_full A case report of glucose transporter 1 deficiency syndrome with growth hormone deficiency diagnosed before starting ketogenic diet
title_fullStr A case report of glucose transporter 1 deficiency syndrome with growth hormone deficiency diagnosed before starting ketogenic diet
title_full_unstemmed A case report of glucose transporter 1 deficiency syndrome with growth hormone deficiency diagnosed before starting ketogenic diet
title_short A case report of glucose transporter 1 deficiency syndrome with growth hormone deficiency diagnosed before starting ketogenic diet
title_sort case report of glucose transporter 1 deficiency syndrome with growth hormone deficiency diagnosed before starting ketogenic diet
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448353/
https://www.ncbi.nlm.nih.gov/pubmed/32847563
http://dx.doi.org/10.1186/s13052-020-00888-3
work_keys_str_mv AT tornesegianluca acasereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet
AT pattigiuseppa acasereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet
AT pellegrinmariachiara acasereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet
AT costapaola acasereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet
AT faletraflavio acasereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet
AT faleschinielena acasereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet
AT barbiegidio acasereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet
AT tornesegianluca casereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet
AT pattigiuseppa casereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet
AT pellegrinmariachiara casereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet
AT costapaola casereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet
AT faletraflavio casereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet
AT faleschinielena casereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet
AT barbiegidio casereportofglucosetransporter1deficiencysyndromewithgrowthhormonedeficiencydiagnosedbeforestartingketogenicdiet